Agilon Health Inc (NYSE: AGL) on Monday, soared 17.39% from the previous trading day, before settling in for the closing price of $1.84. Within the past 52 weeks, AGL’s price has moved between $1.80 and $13.76.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 53.71%. The company achieved an average annual earnings per share of -0.17%. With a float of $303.22 million, this company’s outstanding shares have now reached $406.39 million.
The extent of productivity of a business whose workforce counts for 1117 workers is very important to gauge. In terms of profitability, gross margin is 25.86%, operating margin of -6.17%, and the pretax margin is -5.56%.
Agilon Health Inc (AGL) Insider and Institutional Ownership
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of Agilon Health Inc is 26.41%, while institutional ownership is 86.77%. The most recent insider transaction that took place on Sep 12 ’24, was worth 67,188. In this transaction CEO & President of this company bought 20,000 shares at a rate of $3.36, taking the stock ownership to the 67,590 shares. Before that another transaction happened on Nov 29 ’23, when Company’s Director bought 22,300 for $11.22, making the entire transaction worth $250,206. This insider now owns 31,931 shares in total.
Agilon Health Inc (AGL) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.57 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.3) by -0.27. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.17% per share during the next fiscal year.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Agilon Health Inc (AGL) is currently performing well based on its current performance indicators. A quick ratio of 1.29 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
The latest stats from [Agilon Health Inc, AGL] show that its last 5-days average volume of 8.27 million was superior to 4.96 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.82%. Additionally, its Average True Range was 0.30.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 6.07%, which indicates a significant decrease from 26.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 196.05% in the past 14 days, which was higher than the 104.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.2200, while its 200-day Moving Average is $5.1900. Now, the first resistance to watch is $2.2800. This is followed by the second major resistance level at $2.3900. The third major resistance level sits at $2.6000. If the price goes on to break the first support level at $1.9500, it is likely to go to the next support level at $1.7400. The third support level lies at $1.6300 if the price breaches the second support level.
Agilon Health Inc (NYSE: AGL) Key Stats
Market capitalization of the company is 586.92 million based on 411,483K outstanding shares. Right now, sales total 4,316 M and income totals -262,600 K. The company made 1,483 M in profit during its latest quarter, and -30,680 K in sales during its previous quarter.
